 Connection
David Schwartz to Toll-Like Receptor 5
This is a "connection" page, showing publications David Schwartz has written about Toll-Like Receptor 5.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.242 |
|
|
|
-
Sakamachi Y, Wiley E, Trempus CS, Jacobs H, Solis A, Johnson CG, Meng X, Hussain S, Roselli A, Lipinski JH, O'Dwyer DN, Randall TA, Malphurs J, Papas B, Wu BG, Li Y, Kugler MC, Mehta S, Scappini E, Thomas SY, Li JL, Zhou L, Karmaus PW, Lih FB, Fessler MB, McGrath JA, Gibson K, Kass DJ, Gleiberman A, Andrianova E, Walts A, Invernizzi R, Molyneaux PL, Yang IV, Zhang Y, Kaminski N, Segal LN, Schwartz DA, Gudkov AV, Garantziotis S. Toll-like receptor 5 protects against murine lung fibrosis through reduced dysbiosis, and TLR5 deficiency is associated with human IPF. Sci Transl Med. 2026 Jun 03; 18(852):eadw1028.
Score: 0.242
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|